These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 18634444)
1. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia]. Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444 [TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Liu HT; Kuo HC Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272 [TBL] [Abstract][Full Text] [Related]
3. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657 [TBL] [Abstract][Full Text] [Related]
4. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity. Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093 [TBL] [Abstract][Full Text] [Related]
5. Comparisons of urodynamic findings and voiding habits in patients with concomitant benign prostatic hyperplasia and detrusor overactivity presenting with or without the symptom of urgency. Tong YC Urol Int; 2007; 78(3):219-25. PubMed ID: 17406130 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Seki N; Yuki K; Takei M; Yamaguchi A; Naito S Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143 [TBL] [Abstract][Full Text] [Related]
7. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder]. Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379 [TBL] [Abstract][Full Text] [Related]
8. Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia. Tsujimura A; Takao T; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Ueda T; Kiuchi H; Hirai T; Tsujimoto Y; Miura H; Kanno N; Higashino M; Nakamura Y; Nishimura K; Nonomura N Urology; 2011 Nov; 78(5):1058-62. PubMed ID: 21908025 [TBL] [Abstract][Full Text] [Related]
9. Urethral Sensations are Related to the Development of Detrusor Overactivity. Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Ishida H; Matsuta Y; Kusukawa N; Yamauchi H; Takahara N; Watanabe N; Tsuchiyama K; Yokoi S; Akino H Low Urin Tract Symptoms; 2011 Sep; 3(2):59-63. PubMed ID: 26676387 [TBL] [Abstract][Full Text] [Related]
10. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia. Liu N; Man LB; He F; Huang GL; Wang H; Li GZ; Wang JW; Lü YW Chin Med J (Engl); 2012 Nov; 125(21):3778-81. PubMed ID: 23106872 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic. Hanuš T; Zámečník L; Doležal T; Karmazínová Z Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947 [TBL] [Abstract][Full Text] [Related]
12. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia. Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181 [TBL] [Abstract][Full Text] [Related]
13. Association of symptoms with urodynamic findings in men with overactive bladder syndrome. Al-Zahrani AA; Gajewski JB BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556 [TBL] [Abstract][Full Text] [Related]
14. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms? Cornu JN; Grise P Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus. Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211 [TBL] [Abstract][Full Text] [Related]
16. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia]. Bablumyan A Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402 [TBL] [Abstract][Full Text] [Related]
17. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Yokoyama T; Kumon H; Nagai A Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444 [TBL] [Abstract][Full Text] [Related]
18. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study. Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304 [TBL] [Abstract][Full Text] [Related]
19. An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate-receptor antagonist can inhibit premicturition contractions in rats with bladder outlet obstruction. Kitta T; Kakizaki H; Tanaka H; Sano H; Furuno T; Mitsui T; Moriya K; Nonomura K BJU Int; 2007 Jul; 100(1):181-6. PubMed ID: 17488306 [TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and treatment of the overactive bladder syndrome in an aged male patient with voiding difficulty: pharmacological treatment]. Akino H Hinyokika Kiyo; 2005 Sep; 51(9):609-13. PubMed ID: 16229374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]